Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.
about
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterolPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDEfficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by ageTreatment options for moderate-to-very severe chronic obstructive pulmonary disease.Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease.
P2860
Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Olodaterol + tiotropium bromid ...... obstructive pulmonary disease.
@en
type
label
Olodaterol + tiotropium bromid ...... obstructive pulmonary disease.
@en
prefLabel
Olodaterol + tiotropium bromid ...... obstructive pulmonary disease.
@en
P2093
P2860
P1476
Olodaterol + tiotropium bromid ...... obstructive pulmonary disease
@en
P2093
Josuel Ora
Maria Gabriella Matera
Mario Cazzola
P2860
P304
P356
10.1586/17512433.2015.1075389
P407
P577
2015-01-01T00:00:00Z